Fluxion Biosciences (United States)
- Research works
- 56 ▼ 6% vs 2013–17
- Citations
- 922 16.5 per fractional work
- Top-10% rate
- 14.5% record average 16.5%
- Open access
- 45% world 28%
Not ranked overall: Fluxion Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemical Engineering, 7.4×. Every wedge is a field page.
Which keywords describe research at Fluxion Biosciences (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Lab-on-a-Chip, Microfluidic Devices, Regenerative Medicine, Tissue Engineering, Cell Culture, Bioinks, Bioprinting and Microfluidics.
- Droplet Formation
- Crystal Structure
- Biomedical Research
- Neurotransmission
- Homologous Recombination
- 3D Printing
- Calcium Channels
- Neurological Disorders
- Drug Resistance
- Mutational Signatures
- Biosensors
- Targeted Therapy
- Acoustic Manipulation
- Ion Channels
- Hemostasis
- Genomic Instability
- Microfluidics
- Bioinks
- Tissue Engineering
- Microfluidic Devices
- Lab-on-a-Chip
- Regenerative Medicine
- Cell Culture
- Bioprinting
- Inflammation
- Cell Signaling
- Electrode Arrays
- Neural Stimulation
- Particle Separation
- Cancer
- Cancer Genomics
- Thrombosis
- Immune Thrombocytopenic Purpura
- Platelets
- Voltage-Gated Channels
- Cancer Therapy
- Point-of-Care Diagnostics
- Synaptic Plasticity
- Poly(dimethylsiloxane)
- Continuous Flow Chemistry
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Lab-on-a-Chip5▲ 63×3 topics
- Microfluidic Devices5▲ 103×2 topics
- Regenerative Medicine5▲ 39×3 topics
- Tissue Engineering5▲ 16×2 topics
- Cell Culture5▲ 76×2 topics
- Bioinks5▲ 181×1 topic
- Bioprinting5▲ 181×1 topic
- Microfluidics4▲ 88×2 topics
- Inflammation4▲ 3.0×7 topics
- Genomic Instability3▲ 46×2 topics
- Cell Signaling3▲ 17×2 topics
- Hemostasis3▲ 38×2 topics
- Electrode Arrays3▲ 98×1 topic
- Ion Channels3▲ 25×2 topics
- Neural Stimulation3▲ 98×1 topic
- Acoustic Manipulation3▲ 142×1 topic
- Particle Separation3▲ 142×1 topic
- Targeted Therapy3▲ 23×2 topics
- Cancer3▲ 3.4×8 topics
- Biosensors3▲ 8.0×5 topics
- Cancer Genomics3▲ 85×1 topic
- Mutational Signatures3▲ 85×1 topic
- Thrombosis2▲ 19×2 topics
- Drug Resistance2▲ 12×3 topics
- Immune Thrombocytopenic Purpura2▲ 100×1 topic
- Neurological Disorders2▲ 5.7×3 topics
- Platelets2▲ 61×1 topic
- Calcium Channels2▲ 49×1 topic
- Voltage-Gated Channels2▲ 49×1 topic
- 3D Printing2▲ 18×2 topics
- Cancer Therapy2▲ 5.4×4 topics
- Homologous Recombination2▲ 50×2 topics
- Point-of-Care Diagnostics2▲ 40×2 topics
- Neurotransmission2▲ 24×1 topic
- Synaptic Plasticity2▲ 10×1 topic
- Biomedical Research2▲ 41×1 topic
- Poly(dimethylsiloxane)2▲ 64×1 topic
- Crystal Structure2▲ 11×2 topics
- Continuous Flow Chemistry1▲ 69×1 topic
- Droplet Formation1▲ 69×1 topic
Which research topics does Fluxion Biosciences (United States) publish most on?
By volume in 2022–2025: PARP inhibition in cancer therapy, DNA Repair Mechanisms, Single-cell and spatial transcriptomics and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 PARP inhibition in cancer therapy Oncology 1 works
- 2 DNA Repair Mechanisms Molecular Biology 1 works
- 3 Single-cell and spatial transcriptomics Molecular Biology 0 works
- 4 CAR-T cell therapy research Oncology 0 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 6 Nanowire Synthesis and Applications Biomedical Engineering 0 works
- 7 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 8 Cancer Research and Treatments Biotechnology 0 works
- 9 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
- 10 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fluxion Biosciences (United States)'s research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.